- 专利标题： Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
-
申请号： US16551198申请日： 2019-08-26
-
公开(公告)号： US11045564B2公开(公告)日： 2021-06-29
- 发明人: Matthias Eder , Klaus Kopka , Martin Schäfer , Ulrike Bauder-Wüst , Michael Eisenhut , Walter Mier , Martina Benesova
- 申请人： DEUTSCHES KREBSFORSCHUNGSZENTRUM , RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
- 申请人地址： DE Heidelberg; DE Heidelberg
- 专利权人： DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
- 当前专利权人： DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
- 当前专利权人地址： DE Heidelberg; DE Heidelberg
- 代理机构： The Marbury Law Group, PLLC
- 优先权： EP13004991 20131018,EP14175612 20140703
- 主分类号： A61K51/04
- IPC分类号： A61K51/04 ; C07B59/00 ; C07D295/145 ; C07D257/02
摘要：
The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. Thus, the present invention concerns compounds that are represented by the general Formulae (Ia) or (Ib).
信息查询
